Lupin launches Luforbec 100/6 μg pMDI EP News Bureau Aug 24, 2021 It is the first branded generic alternative to Fostair 100/6 μg pMDI for the treatment of asthma and COPD in the UK
Lupin gets UK marketing authorisation for Luforbec 100/6 µg pMDI EP News Bureau Jun 14, 2021 Luforbec 100/6 µg pMDI is indicated for regular treatment of asthma and for the symptomatic treatment of patients with severe COPD
